These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 9031752)

  • 21. Alteration of binding sites for [3H]P1075 and [3H]glibenclamide in renovascular hypertensive rat aorta.
    He HM; Long CL; Zhang LZ; Fu AL; Wang H
    Acta Pharmacol Sin; 2005 Jan; 26(1):69-76. PubMed ID: 15659117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparations.
    Gopalakrishnan M; Johnson DE; Janis RA; Triggle DJ
    J Pharmacol Exp Ther; 1991 Jun; 257(3):1162-71. PubMed ID: 1904493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The high-affinity sulphonylurea receptor regulates KATP channels in nerve terminals of the rat motor cortex.
    Lee K; Dixon AK; Rowe IC; Ashford ML; Richardson PJ
    J Neurochem; 1996 Jun; 66(6):2562-71. PubMed ID: 8632183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationship of glibenclamide analogs: a comparison of potency as levcromakalim antagonists in rat aorta vs. affinity for [3H]-glibenclamide binding to membranes from rat cerebral cortex.
    Challinor-Rogers JL; Kong DC; Iskander MN; McPherson GA
    J Pharmacol Exp Ther; 1995 May; 273(2):778-86. PubMed ID: 7752080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The binding site for [3H]glibenclamide in the rat cerebral cortex does not recognize K-channel agonists or antagonists other than sulphonylureas.
    Angel I; Bidet S
    Fundam Clin Pharmacol; 1991; 5(2):107-15. PubMed ID: 1649112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [125I]A-312110, a novel high-affinity 1,4-dihydropyridine ATP-sensitive K+ channel opener: characterization and pharmacology of binding.
    Davis-Taber R; Molinari EJ; Altenbach RJ; Whiteaker KL; Shieh CC; Rotert G; Buckner SA; Malysz J; Milicic I; McDermott JS; Gintant GA; Coghlan MJ; Carroll WA; Scott VE; Gopalakrishnan M
    Mol Pharmacol; 2003 Jul; 64(1):143-53. PubMed ID: 12815170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of pH upon the inhibition by sulphonylurea drugs of ATP-sensitive K+ channels in cardiac muscle.
    Findlay I
    J Pharmacol Exp Ther; 1992 Jul; 262(1):71-9. PubMed ID: 1625214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of the hypoglycaemic drug (-)-AZ-DF-265 on ATP-sensitive potassium channels in rat pancreatic beta-cells.
    Ronner P; Hang TL; Kraebber MJ; Higgins TJ
    Br J Pharmacol; 1992 Jun; 106(2):250-5. PubMed ID: 1393260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ATP-sensitive potassium channels and substances affecting them].
    Pospísilová Y
    Vnitr Lek; 1998 Jul; 44(7):435-8. PubMed ID: 9748883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phospholipids as modulators of K(ATP) channels: distinct mechanisms for control of sensitivity to sulphonylureas, K(+) channel openers, and ATP.
    Krauter T; Ruppersberg JP; Baukrowitz T
    Mol Pharmacol; 2001 May; 59(5):1086-93. PubMed ID: 11306691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation by nucleotides of binding sites for [3H]glibenclamide in rat aorta and cardiac ventricular membranes.
    Zhu QL; He HM; Xiao WB; Wang H
    J Cardiovasc Pharmacol; 2001 May; 37(5):522-31. PubMed ID: 11336103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of KATP channel and sulphonylurea receptor in the rat clonal insulin-secreting cell line, CRI-D11.
    Khan RN; Hales CN; Ozanne SE; Adogu AA; Ashford ML
    Proc Biol Sci; 1993 Sep; 253(1338):225-31. PubMed ID: 7694299
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endothelium-dependent and -independent vasorelaxation by a theophylline derivative MCPT: roles of cyclic nucleotides, potassium channel opening and phosphodiesterase inhibition.
    Lo YC; Tsou HH; Lin RJ; Wu DC; Wu BN; Lin YT; Chen IJ
    Life Sci; 2005 Jan; 76(8):931-44. PubMed ID: 15589969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence that imidazol(id)ine- and sulphonylurea-based antagonists of cromakalim act at different sites in the rat thoracic aorta.
    Challinor JL; McPherson GA
    Clin Exp Pharmacol Physiol; 1993; 20(7-8):467-75. PubMed ID: 8403526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A specific binding site for K+ channel openers in rat aorta.
    Bray KM; Quast U
    J Biol Chem; 1992 Jun; 267(17):11689-92. PubMed ID: 1601843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The involvement of ATP-sensitive potassium channels in beta 2-adrenoceptor agonist-induced vasodilatation on rat diaphragmatic microcirculation.
    Chang HY
    Br J Pharmacol; 1997 Jul; 121(5):1024-30. PubMed ID: 9222563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mg(2+)-dependent inhibition of KATP by sulphonylureas in CRI-G1 insulin-secreting cells.
    Lee K; Ozanne SE; Hales CN; Ashford ML
    Br J Pharmacol; 1994 Feb; 111(2):632-40. PubMed ID: 8004407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of BTS 67 582, a novel antidiabetic agent, in normal and diabetic rats.
    Jones RB; Dickinson K; Anthony DM; Marita AR; Kaul CL; Buckett WR
    Br J Pharmacol; 1997 Mar; 120(6):1135-43. PubMed ID: 9134227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mitochondrial sulfonylurea receptor: identification and characterization.
    Szewczyk A; Wójcik G; Lobanov NA; Nałecz MJ
    Biochem Biophys Res Commun; 1997 Jan; 230(3):611-5. PubMed ID: 9015372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of sulphonylureas on the vasodilatory response evoked by K(ATP) channel openers.
    Ravel D; Levens N; Félétou M; Néliat G; Auclair J; Bouskela E
    Fundam Clin Pharmacol; 2003 Feb; 17(1):61-9. PubMed ID: 12588631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.